TC
TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
Organization · NY
Hires government relations
Who they hire
What they lobby on
Outreach and monitoring regarding: -Appropriations for fiscal year 2024 and 2025, including NIH funding and funding for the Lorna Breen Act. -H.R. 5894 / S. 2624, Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2024, and for other purposes. Provisions related to Facilities and Administrative costs. -H.R. 9029 / Senate Draft, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025.
Outreach and monitoring regarding: -Public health issues. -Mental health issues. -Telehealth issues. -Maternal health issues. -Gun violence as a public health issue. -FDA regulation of Laboratory Developed Tests. -Policies focused on reducing barriers to participating in clinical trials. -H.R. 7418, To amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants. -H.R. 8412, Clinical Trial Modernization Act.
-Bipartisan Workforce Pell Act.
Outreach and monitoring regarding: -Appropriations for fiscal year 2024, including NIH funding, PEPFAR funding. -H.R. 5894 / S. 2624, Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2024, and for other purposes. Provisions related to Facilities and Administrative costs. -H.R.2882, Further Consolidated Appropriations Act, 2024. -Funding for Injury Control Research Centers.
Outreach and monitoring regarding: -Public health issues. -Mental health issues. -Gun violence as a public health issue. -FDA regulation of Laboratory Developed Tests. -CMS Physician Fee Schedule. -Policies focused on reducing barriers to participating in clinical trials. -H.R. 7418, To amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants.